Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | HPGD | P15428 | 6/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | ABL1 | P00519 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | MOK | Q9UQ07 | 1/20 | 0.38 |
| ▸ | PDE5A | O76074 | 1/20 | 0.37 |
| ▸ | AVPR1B | P47901 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4878882 | 0.90 | ALDH1A1 (0.44) | CD274ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL4867756 | 0.89 | ALDH1A1 (0.45) | ALDH1A1HPGDKDM4EHSD17B10POLB | |
| SCHEMBL4877125 | 0.89 | ALDH1A1 (0.45) | ALDH1A1HPGDKDM4EHSD17B10POLB | |
| SCHEMBL4870548 | 0.89 | CD274 (0.43) | CD274ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL4874969 | 0.89 | ALDH1A1 (0.43) | ALDH1A1HPGDKDM4EHSD17B10POLB | |
| SCHEMBL4876084 | 0.85 | ALDH1A1 (0.43) | ALDH1A1HPGDKDM4EHSD17B10POLB | |
| SCHEMBL4877272 | 0.84 | ALDH1A1 (0.43) | ALDH1A1HPGDKDM4EHSD17B10POLB | |
| SCHEMBL4874635 | 0.84 | ALDH1A1 (0.43) | ALDH1A1HPGDKDM4EHSD17B10POLB | |
| SCHEMBL14305260 | 0.83 | HTT (0.36) | CD274ALDH1A1HPGDABL1PDE5A | |
| SCHEMBL4877164 | 0.81 | AVPR1B (0.44) | ALDH1A1HPGDKDM4EHSD17B10POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080051384-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. | 2008-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051384-A1 | ANTIVIRAL AGENTS | EIF2AK2, MAVS, ZC3HAV1 | CD274 4210/4885ALDH1A1 1357/4885HPGD 2973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.